Researches discuss NIH's nanotechnology initiative
Article Abstract:
The National Institutes of Health is prepared to allocate money for nanotechnology development, but potential researchers claim the funds will be awarded to theoretical work rather than new tool development, in which the most research is needed.
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
Government expenditures, Biochemistry, Scientific Research and Development Services, Admin. of public health programs, General Science & Basic Research, Research
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Gene therapy safety issues come to fore
Article Abstract:
With about 6 deaths, adenovirus-based gene therapy studies have undergone intensified review by the NIH, and the FDA.
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 1998
Product standards, safety, & recalls, Government domestic functions, Regulation of Agricultural Marketing and Commodities, Food & Drug Administration, Cellular Biology, Cytology
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States
Similar abstracts:
- Abstracts: Self-service technology effectiveness: the role of design features and individual traits. The impact of technology on the quality-value-loyalty chain: a research agenda
- Abstracts: Image Associates diversifies to thrive. Photo Craft Lab helps bring Everest climber back to life. La Jolla Photo & Imaging goes completely digital
- Abstracts: GM food singled out for labeling in the US. Scrutiny of gene therapy broadens, intensifies
- Abstracts: France critiques its incubators before refinancing. Spanish R&D budget boosts biotechnology. French genomics setup questioned
- Abstracts: Three-way merger regenerates new company. Chiron buys PathoGenesis
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.